Hantavirus Infections

Infecciones por hantavirus

Hantaviruses are the causative agents of hantavirus pulmonary syndrome in humans in the Americas; The primary reservoirs are in the rodents of the subfamily Sigmodontinae. In South America, cases of hantavirus pulmonary syndrome caused by numerous viral genotypes have been diagnosed. In Colombia, different serological studies have reported the circulation of hantavirus in humans and rodents. These viruses act in an intimate association with a rodent species that serves as a reservoir and have a distribution around the wild rodent, being limited to a specific geographic region. In South America, the first HPS-associated hantavirus was described in 1993 in Brazil and was called Juquitiva and from 1993 to 2012, more than 1400 cases had been identified in Brazil. This syndrome should be suspected in all patients with respiratory distress syndrome of unclear etiology, in areas endemic for the disease, especially if accompanied by fever, marked leukocytosis and thrombocytopenia and bilateral interstitial infiltrates. Hemorrhagic febrile syndrome has not yet been described in the Americas. There are no clinical or laboratory signs that are pathognomonic of hantavirus infection. The treatment is based on adequate hydration, use of antipyretics and anti-inflammatories and patients with signs of severity should establish a more aggressive management. Triage is indispensable, patients with co-morbidities have a higher mortality risk and therefore should be hospitalized. Future research in Colombia should be directed to multidisciplinary studies that include viral isolation, different clinical forms of case presentation, epidemiological differences, risk factors, and taxonomy of viruses and rodents.

1. Clement J, Maes P, Lagrou K, Van Ranst, Lameire N. A unifying hypothesis and a simple name for a complex globally emerging infection hantavirus disease. Eur J. Clin Microbiol Infec Dis. 2012;31(1):1-5. https://doi.org/10.1007/s10096-011-1456-y
3. Mattar S, Parra M. Serologic evidence of hantavirus infection in human, Colombia. Emerge. Infect. Dis. 2004; 10:2263-2264. https://doi.org/10.3201/eid1012.040821
5. Alemán A, Iguarán H, Puerta H, Cantillo C, Mills J, Ariz W, et al. Primera evidencia serológica de infección por hantavirus en roedores en Colombia. Rev Salud Pública. 2006;8(1):1-12. https://doi.org/10.1590/S0124-00642006000400001
7. Londo-o AF, Díaz FJ, Agudelo-Florez P, Levis S, Rodas JD. Genetic evidence of hantavirus infections in wild rodents from northwestern Colombia. Vector Borne Zoonotic Dis. 2011; 11:701-870. https://doi.org/10.1089/vbz.2010.0129
9. Guzmán C, Mattar S, Levis S, Pini N, Figuereido LT, Mills J, et al. Seroprevalence of hantavirus in humans and rodents using Araraquara and Maciel antigens, Caribbean Colombia. Mem Inst Oswaldo Cruz. 2013;108(2):167-171. https://doi.org/10.1590/0074-0276108022013007
11. Mattar S, Tique V, Miranda J, Montes E, Garzon D. Undifferentiated tropical febrile illness in Cordoba, Colombia: Not everything is dengue. J Infect Public Health. 2017;S1876-0341(16)30153-30158.
13. Schmaljohn C. Bunyaviridae. In: Wilkins LW, editor. Fields virology. 5th edition. Philadelphia; Lippincott Williams & Wilkins; 2007. p. 1742-89.
15. Albornoz A, Hoffmann AB, Lozach PY, Tischler ND. Early bunyavirus-host cell interactions. Viruses. 2016; 8(5):143-164. https://doi.org/10.3390/v8050143
17. Moreno SHN, Rangel GSI, Thompson BMR, García MJL, Lara LM, Pi-a LC. Síndrome pulmonar por hantavirus, una amenaza latente en México. Rev Esp Méd Quir. 2014; 19:96-103.
19. Cifuentes-Mu-oz N, Salazar-Quiroz N, Tischler ND. Hantavirus Gn and Gc. Envelope glycoproteins: key structural units for virus cell entry and virus assembly. Viruses. 2014;21;6(4):1801-1822.
21. Spiropoulou C, Gloldsmith C, Shoemaker T, Peters C, Compans R. S Sin Nombre virus glycoprotein trafficking. Virology.2003;308:48-63. https://doi.org/10.1016/S0042-6822(02)00092-2
23. Montoya-Ruiz C, Díaz FJ, Rodas JD. Recent evidence of hantavirus circulation in the American tropic. Viruses. 2014;14;6(3):1274-1293.
25. Salazar-Bravo J, Ruedas LA, Yates TL. Mammalian reservoirs of arenaviruses. Curr Top Microbiol Immunol 2002; 262:25–63. https://doi.org/10.1007/978-3-642-56029-3_2
27. Navarrete M, Hott M, Caroca J, Leyton L, Venegas N, Ismail K, et al. Correlación entre criterios clínicos y de laboratorio de casos notificados por sospecha de hantavirosis y el resultado de la técnica de referencia. Rev. chil. Infectol 2016; 33(3): 275-281. https://doi.org/10.4067/S0716-10182016000300004
29. Jonsson CB, Figueiredo LTM, Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev 2010;23(2):412-441. https://doi.org/10.1128/CMR.00062-09
31. Padula P, Edelstein A, Miguel S, López N, Rossi C, Rabinobich R. Brote epidémico del síndrome pulmonar por hantavirus en la Argentina, evidencia molecular de la transmisión de persona a persona del virus Andes. Medicina (Buenos Aires) 1998; 58(l):27-36.
33. Nichol ST, Spiropoulou CF, Morzunov S, Rollin PE, Ksiazek TG, Feldmann H, et al. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 1993; 262: 914-917. https://doi.org/10.1126/science.8235615
35. Nú-ez JJ, Fritz L, Knust B, Buttke D, Enge B, Novak M, et al Hantavirus Infections among Overnight Visitors to Yosemite National Park, California, USA, 2012. Emerg Infect Dis 2014; 20(3):386-393. https://doi.org/10.3201/eid2003.131581
37. Da Silva MV, Vasconcelos MJ, Hidalgo NTR, Veiga APR, Canzian M, Marotto PCF, et al. Hantavirus pulmonary syndrome. Report of the first three cases in São Paulo, Brazil. Rev Inst Med Trop Sao Paulo 1997; 39:231–234. https://doi.org/10.1590/S0036-46651997000400010
39. Iglesias AA, Bellomo CM, Martínez VP. Síndrome pulmonar por hantavirus en Buenos Aires, 2009-2014. Medicina (B. Aires). 2016;76(1):1-9.
41. Pantozzi F, Bolzán A, Masana M. Perfil clínico epidemiológico de infección por hantavirus en la provincia de Buenos, Aires, Argentina, periodo 1996- 2009. Rev Cil Salud Pública 2011;15(3):155-164. https://doi.org/10.5354/0717-3652.2011.17709
43. Belomo C, Nudelman J, Kwaszka R, Vásquez G, Cantoni G, et al. Expansión geográfica del síndrome pulmonar por hantavirus en la Argentina informe del caso más austral. Medicina (Buenos Aires). 2009; 69:647- 650
45. Toro J, Vega AS, Khan JN, Mills P, Padula W, Terry Z, et al. An outbreak of hantavirus pulmonary syndrome, Chile, 1997. Emerg Infect Dis. 1998; 4:687-694. https://doi.org/10.3201/eid0404.980425
47. Ministerio de Salud, Departamento de Epidemiología: Boletín Epidemiológico de Hantavirus. http://epi.minsal.cl/epi/html/ bolets/reportes/Hantavirus/Hantavirus.pdf.
49. Bharadwaj M, Botten J, Torrez-Martinez N, Hjelle B. Río Mamore virus: genetic characterization of a newly recognized hantavirus of the pygmy rice rat, Oligoryzomys microtis, from Bolivia. Am J Trop Med Hyg. 1997;57(3):368-374. https://doi.org/10.4269/ajtmh.1997.57.368
51. Delfraro A, Tomé L, D' Elía G, Clara M, Achával F, Russi J, et al. Juquitiba-Like hantavirus from 2 nonrelated rodent species, Uruguay. Emerg Infect Dis. 2008;14 (9):1447-451. https://doi.org/10.3201/eid1409.080455
53. Johnson AM, Bowen MD, Ksiazek TG, Williams RJ, Bryan RT, Mills JN, et al. Laguna Negra virus associated with HPS in western Paraguay and Bolivia. Virology 1997;115-127. https://doi.org/10.1006/viro.1997.8840
55. Isurralde A, Paéz M. Situación epidemiológica del síndrome pulmonar por hantavirus (SPH). Paraguay 200-2004. Mem. Inst Invest Cienc Salud. 2008;6(1):28-33.
57. Casapía M, Mamani E, García MP, Miraval ML, Valencia P, Quino AH, et al. Síndrome pulmonar por hantavirus (virus Río Mamoré) en la Amazonia Peruana. Rev Peru Med Exp salud pública. 2012; 29(3): 390-395. https://doi.org/10.1590/S1726-46342012000300016
59. Armien B, Pascale JM, Bayard V, Mu-oz C, Mosca I, Guerrero G, et al. High seroprevalence of hantavirus infection on the Azuero peninsula of Panama. Am J Trop Med Hyg. 2004;70(6):682-687.
61. Blanco P, Arroyo S, Corrales H, Pérez J, Álvarez L, Castellar A. Evidencia serológica de infección por hantavirus (Bunyaviridae: Hantavirus) en roedores del Departamento de Sucre, Colombia. Rev. salud pública. 2012;4(5):755-764.
63. Kumar A, Krishnamurthy K, Nielsen A. Hantavirus infection among children hospitalized for febrile illness suspected to be dengue in Barbados. J Infec Public Health. 2016;9(1):81-87. https://doi.org/10.1016/j.jiph.2015.06.004
65. Lima DM, Sabino-Santos J, Oliveira AC, Fontes RM, Colares JK, Araújo FM, et al. Hantavirus infection in suspected dengue cases from State of Ceará, Brazil. Rev Soc Bras Med Trop. 2011; 44(6):795-6. https://doi.org/10.1590/S0037-86822011000600031
67. Baró AM, Vergara OJ, Navarrete CM. Hantavirus en Chile: revisión y análisis de casos desde 1975. Rev. méd. Chile. 1999;127(12):1513-152. https://doi.org/10.4067/S0034-98871999001200015
69. Yoshimatsu K, Arikawa J. Serological diagnosis with recombinant N antigen for hantavirus infection. Virus Res 2014; 187:77–83 https://doi.org/10.1016/j.virusres.2013.12.040
71. Lederer S, Lattwein E, Hanke M, Sonnenberg K, Stoecker W, et al. Indirect immunofluorescence assay for the simultaneous detection of antibodies against clinically important old and new world hantaviruses. PLoS Negl Trop Dis 2013;7(4): e2157. doi:10.1371/journal.pntd.0002157. https://doi.org/10.1371/journal.pntd.0002157
73. Amada T, Yoshimatsu K, Koma T, Shimizu K, Gamage C, et al. Development of an immunochromatography strip test based on truncated nucleocapsid antigens of three representative hantaviruses. Virol J. 2014; 11:87. doi: 10.1186/1743-422X-11-87. https://doi.org/10.1186/1743-422X-11-87
75. Mattar S, Guzmán C, Figueiredo LT. Diagnosis of hantavirus infection in humans. Expert Rev Anti Infect Ther. 2015; 13(8):939-946. https://doi.org/10.1586/14787210.2015.1047825
77. Vial C, Martinez-Valdebenito C, Rios S, Martinez J, Vial PA, Ferres M, et al. Molecular method for the detection of Andes hantavirus infection: validation for clinical diagnostics. Diagn Microbiol Infect Dis. 2016;84(1):36-39. https://doi.org/10.1016/j.diagmicrobio.2015.07.019
79. Schwarz TF, Zaki SR, Morzunov S, Peters CJ, Nichol S.T. Detection and sequence confirmation of Sin Nombre virus RNA in paraffin-embedded human tissues using one-step RT-PCR. J Virol Methods.1995; 51(2-3):349-356. https://doi.org/10.1016/0166-0934(94)00142-4
81. Manigold T, Vial P. Human hantavirus infections: epidemiology, clinical features, pathogenesis and immunology. Swiss Med Wkly. 2014;144: w13937. https://doi.org/10.4414/smw.2014.13937
83. Martinez VP, Bellomo C, San Juan J, Pinna D, Forlenza R, Elder M, et al. Person-to-person transmission of Andes virus. Emerg Infect Dis. 2005;11(12):1848-1853. https://doi.org/10.3201/eid1112.050501
85. Firth C, Tokarz R, Simith D, Nunes M, Bhat M, Elizabeth R, et al. Diversity and distribution of hantaviruses in South America. Virol J. 2012;86(24):13756-13766. https://doi.org/10.1128/JVI.02341-12
87. Westovera J, Sefinga E, Baileya W, Van Wettere AJ, Junga K, Dagleya A, et al. Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses Antiviral Res. 2016 126:62–68. https://doi.org/10.1016/j.antiviral.2015.12.006
89. Mertz GJ, Miedzinski L, Goade D, Pavia AT, Hjelle B, Hansbarger C, et al. Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis. 2004;39(9):1307-1313. https://doi.org/10.1086/425007